Affymetrix, Asuragen Team on MDx Kits | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Asuragen today said that it has signed a collaboration with Affymetrix to develop RNA Control Kits for molecular diagnostic applications.

Under the agreement, Asuragen will develop and manufacture the kits, which are intended for use with in vitro transcription reagent kits for clinical molecular diagnostic applications, for Affymetrix. The Austin, Texas-based firm said that the kits will enable Affy to supply its molecular diagnostic partners with complete solutions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.